Hyperfine, Inc. (HYPR): Price and Financial Metrics


Hyperfine, Inc. (HYPR): $2.06

-0.17 (-7.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HYPR Stock Price Chart Interactive Chart >

Price chart for HYPR

HYPR Price/Volume Stats

Current price $2.06 52-week high $16.61
Prev. close $2.23 52-week low $1.90
Day low $2.06 Volume 125,200
Day high $2.18 Avg. volume 194,997
50-day MA $2.77 Dividend yield N/A
200-day MA $5.88 Market Cap 144.88M

Hyperfine, Inc. (HYPR) Company Bio


Hyperfine, Inc. operates as a medical imaging device company. It offers Swoop system, a portable magnetic resonance imaging system. The company was founded in 2014 and is based in Guilford, Connecticut.


HYPR Latest News Stream


Event/Time News Detail
Loading, please wait...

HYPR Latest Social Stream


Loading social stream, please wait...

View Full HYPR Social Stream

Latest HYPR News From Around the Web

Below are the latest news stories about Hyperfine Inc that investors may wish to consider to help them evaluate HYPR as an investment opportunity.

Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

Cutting-edge imaging technology aims to improve point-of-care triaging for patients in Northern Ontario where access to conventional MRI is currently unavailableGUILFORD, Conn. and MOOSE FACTORY, Ontario, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen's University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health serv

Yahoo | February 16, 2022

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

Creators of the world’s first FDA-cleared portable MRI scales executive team for its next phase of development Dr. Chip Truwit, Senior Medical Director, Hyperfine Dr. Chip Truwit, Senior Medical Director, Hyperfine GUILFORD, Conn., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hyperfine Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, today announced the appointment of Dr. Chip Truwit as senior medical director. For more than 30 years, Truwit ha

Yahoo | February 8, 2022

Monashee Investment Management LLC Buys Vanguard Total Stock Market ETF, Hyperfine Inc, Agree ...

Investment company Monashee Investment Management LLC (Current Portfolio) buys Vanguard Total Stock Market ETF, Hyperfine Inc, Agree Realty Corp, Pardes Biosciences Inc, DocGo Inc, sells Maravai LifeSciences Holdings Inc, SomaLogic Inc, MoneyLion Inc, RBC Bearings Inc, BioAtla Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Monashee Investment Management LLC.

Yahoo | February 7, 2022

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

World’s first FDA-cleared portable MRI expands leading neurosurgery suite’s tech capabilities for novel diagnostic and therapeutic approachesGUILFORD, Conn. and MINNEAPOLIS, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)™ device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care

Yahoo | January 19, 2022

Hyperfine Reports Preliminary Unaudited 2021 Revenue and Swoop® System Installations

GUILFORD, Conn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2021. Preliminary unaudited total revenue for the fourth quarter 2021 is expected to be approximately $0.362 to $0.437 million. Preliminary unaudited total revenue for the full year 2021 is expected to be a

Yahoo | January 10, 2022

Read More 'HYPR' Stories Here

HYPR Price Returns

1-mo -25.63%
3-mo -44.47%
6-mo -71.66%
1-year -78.83%
3-year N/A
5-year N/A
YTD -71.59%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5081 seconds.